Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis

INTRODUCTION: Bronchiectasis is a long-term lung condition, with dilated bronchi, chronic inflammation, chronic infection and acute exacerbations. Recurrent exacerbations are associated with poorer clinical outcomes such as increased severity of lung disease, further exacerbations, hospitalisations,...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Miranda, Wilson, Nina, Homer, Tara Marie, Simms, Laura, Steel, Alison, Maier, Rebecca, Wason, James, Ternent, Laura, Abouhajar, Alaa, Allen, Maria, Joyce, Richard, Hildreth, Victoria, Lakey, Rachel, Cherlin, Svetlana, Walker, Adam, Devereux, Graham, Chalmers, James D, Hill, Adam T, Haworth, Charles, Hurst, John R, De Soyza, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423789/
https://www.ncbi.nlm.nih.gov/pubmed/37562935
http://dx.doi.org/10.1136/bmjopen-2023-071906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423789/
https://www.ncbi.nlm.nih.gov/pubmed/37562935
http://dx.doi.org/10.1136/bmjopen-2023-071906

Ejemplares similares